Stock listing
NASDAQ:RKDA Arcadia Biosciences, Inc. Stock
Home listing (NASDAQ) of Arcadia Biosciences, Inc.
Follow Arcadia Biosciences, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:RKDA
$0.173 USD -0.015 (-8.1%)
Close on Nov 20, 2026
- Day range
- $0.160 – $0.180 USDNov 20, 2026
- Volume
- 119,029 sharesNov 20, 2026
- Market cap
- $1.05M USDAt the close on Nov 20, 2026 · price × 6.07M shares outstanding
- 52-week range
- $0.111 – $3.870 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $597,024 USDMedian day 173,100 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:RKDA · Home | $0.173 USD | -0.015 (-8.1%) | 119,029 | $0.165 | $0.180 | $0.160 | $0.188 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:RKDA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.173 | -0.015 | -8.1% | $0.165 | $0.180 | $0.160 | 119,029 | |
| $0.188 | -0.002 | -1.0% | $0.184 | $0.197 | $0.180 | 137,934 | |
| $0.190 | -0.004 | -2.0% | $0.189 | $0.194 | $0.185 | 172,914 | |
| $0.194 | -0.024 | -11.2% | $0.212 | $0.212 | $0.193 | 154,937 | |
| $0.218 | -0.004 | -1.8% | $0.210 | $0.225 | $0.186 | 673,794 | |
| $0.222 | -0.016 | -6.6% | $0.185 | $0.233 | $0.177 | 2,562,114 | |
| $0.238 | +0.073 | +44.1% | $0.156 | $0.288 | $0.146 | 20,409,107 | |
| $0.165 | -0.001 | -0.5% | $0.170 | $0.170 | $0.144 | 206,806 | |
| $0.166 | +0.005 | +3.0% | $0.165 | $0.171 | $0.155 | 122,206 | |
| $0.161 | -0.006 | -3.6% | $0.159 | $0.167 | $0.156 | 173,100 | |
| $0.167 | +0.009 | +5.7% | $0.154 | $0.170 | $0.142 | 334,500 | |
| $0.158 | +0.003 | +1.9% | $0.147 | $0.170 | $0.146 | 125,100 | |
| $0.155 | -0.001 | -0.6% | $0.144 | $0.160 | $0.143 | 112,200 | |
| $0.156 | -0.002 | -1.3% | $0.155 | $0.157 | $0.132 | 248,700 | |
| $0.158 | -0.013 | -7.6% | $0.163 | $0.166 | $0.132 | 844,800 | |
| $0.171 | +0.013 | +8.2% | $0.159 | $0.177 | $0.153 | 4,028,500 | |
| $0.158 | -0.002 | -1.3% | $0.161 | $0.162 | $0.155 | 69,600 | |
| $0.160 | +0.008 | +5.3% | $0.154 | $0.160 | $0.152 | 75,500 | |
| $0.152 | -0.010 | -6.2% | $0.158 | $0.162 | $0.150 | 63,900 | |
| $0.162 | 0.000 | 0.0% | $0.157 | $0.164 | $0.144 | 213,700 | |
| $0.162 | +0.004 | +2.5% | $0.156 | $0.170 | $0.151 | 530,900 | |
| $0.158 | +0.005 | +3.3% | $0.152 | $0.158 | $0.143 | 185,500 | |
| $0.153 | +0.008 | +5.5% | $0.139 | $0.155 | $0.137 | 257,900 | |
| $0.145 | -0.020 | -12.1% | $0.160 | $0.160 | $0.111 | 1,155,100 | |
| $0.165 | -0.039 | -19.1% | $0.190 | $0.190 | $0.160 | 988,400 | |
| $0.204 | +0.003 | +1.5% | $0.183 | $0.205 | $0.182 | 726,100 | |
| $0.201 | -0.007 | -3.4% | $0.204 | $0.215 | $0.159 | 33,836,900 | |
| $0.208 | -0.018 | -8.0% | $0.200 | $0.230 | $0.187 | 21,283,500 | |
| $0.226 | -0.038 | -14.4% | $0.257 | $0.260 | $0.210 | 761,700 | |
| $0.264 | -0.010 | -3.6% | $0.275 | $0.289 | $0.232 | 390,200 | |
| $0.274 | -0.013 | -4.5% | $0.290 | $0.290 | $0.263 | 210,100 | |
| $0.287 | -0.011 | -3.7% | $0.295 | $0.300 | $0.270 | 311,200 | |
| $0.298 | +0.011 | +3.8% | $0.284 | $0.307 | $0.273 | 765,300 | |
| $0.287 | -0.001 | -0.3% | $0.288 | $0.292 | $0.270 | 154,200 | |
| $0.288 | +0.004 | +1.4% | $0.270 | $0.288 | $0.267 | 208,300 | |
| $0.284 | +0.004 | +1.4% | $0.270 | $0.289 | $0.255 | 936,300 | |
| $0.280 | -0.001 | -0.4% | $0.259 | $0.289 | $0.222 | 21,107,500 | |
| $0.281 | -0.027 | -8.8% | $0.305 | $0.306 | $0.250 | 1,000,000 | |
| $0.308 | 0.000 | 0.0% | $0.301 | $0.318 | $0.285 | 2,850,800 | |
| $0.308 | -0.008 | -2.5% | $0.300 | $0.310 | $0.279 | 689,400 | |
| $0.316 | -0.110 | -25.8% | $0.321 | $0.349 | $0.310 | 887,100 | |
| $0.426 | -0.022 | -4.9% | $0.445 | $0.680 | $0.280 | 25,504,300 | |
| $0.448 | +0.008 | +1.8% | $0.466 | $0.466 | $0.420 | 10,200 | |
| $0.440 | -0.014 | -3.1% | $0.460 | $0.466 | $0.432 | 8,200 | |
| $0.454 | -0.024 | -5.0% | $0.447 | $0.499 | $0.443 | 46,600 | |
| $0.478 | +0.018 | +3.9% | $0.440 | $0.483 | $0.431 | 25,200 | |
| $0.460 | +0.029 | +6.7% | $0.410 | $0.480 | $0.410 | 43,100 | |
| $0.431 | -0.018 | -4.0% | $0.449 | $0.449 | $0.426 | 29,700 | |
| $0.449 | +0.018 | +4.2% | $0.430 | $0.449 | $0.410 | 173,100 | |
| $0.431 | -0.022 | -4.9% | $0.435 | $0.443 | $0.400 | 19,100 | |
| $0.453 | -0.027 | -5.6% | $0.450 | $0.472 | $0.450 | 21,400 | |
| $0.480 | +0.010 | +2.1% | $0.460 | $0.480 | $0.450 | 34,400 | |
| $0.470 | -0.003 | -0.6% | $0.470 | $0.480 | $0.448 | 72,000 | |
| $0.473 | +0.001 | +0.2% | $0.469 | $0.480 | $0.465 | 13,000 | |
| $0.472 | -0.038 | -7.5% | $0.502 | $0.505 | $0.460 | 78,800 | |
| $0.510 | +0.006 | +1.2% | $0.486 | $0.510 | $0.480 | 35,600 | |
| $0.504 | -0.015 | -2.9% | $0.505 | $0.540 | $0.490 | 68,400 | |
| $0.519 | -0.011 | -2.1% | $0.539 | $0.540 | $0.481 | 63,700 | |
| $0.530 | +0.017 | +3.3% | $0.500 | $0.549 | $0.500 | 155,400 | |
| $0.513 | -0.002 | -0.4% | $0.500 | $0.514 | $0.478 | 50,600 | |
| $0.515 | +0.025 | +5.1% | $0.500 | $0.515 | $0.480 | 108,600 | |
| $0.490 | +0.009 | +1.9% | $0.466 | $0.500 | $0.464 | 56,800 | |
| $0.481 | +0.023 | +5.0% | $0.478 | $0.500 | $0.440 | 264,900 | |
| $0.458 | -0.004 | -0.9% | $0.470 | $0.470 | $0.445 | 40,500 | |
| $0.462 | +0.020 | +4.5% | $0.451 | $0.463 | $0.451 | 62,600 |
Splits
2 splits since 2018 · NASDAQ:RKDA · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-40 | Consolidation | |
| 1-for-20 | Consolidation |
- Ticker
- NASDAQ:RKDA
- Asset type
- Stock
- Sector
- Consumer goods
- Industry
- Food & drinks
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 12, 2026
Arcadia Biosciences (RKDA) Announces Third Quarter 2026 Financial Results and Business Highlights
Latest news
Arcadia Biosciences (RKDA) Announces Third Quarter 2026 Financial Results and Business Highlights
Nov 12, 2026
Closed $0.218 (-1.8%) on Nov 13, 2026
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
Aug 13, 2026
Closed $0.625 (+9.6%) on Aug 14, 2026
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Jun 12, 2026
Closed $0.918 (-10.9%) on Jun 15, 2026
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Jun 11, 2026
Closed $1.07 (+18.5%) on Jun 11, 2026
Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights
May 14, 2026
Closed $0.956 (-10.7%) on May 15, 2026
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights
Mar 26, 2026
Closed $1.52 (-10.5%) on Mar 26, 2026
Arcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds
Jan 12, 2026
Closed $2.43 (-11.6%) on Jan 12, 2026
Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources
Dec 26, 2025
Closed $2.60 (-14.5%) on Dec 26, 2025
Arcadia Biosciences, Inc. on 6ix
- Sector
- Consumer goods
- Industry
- Food & drinks
- News releases
- 8 in the last 12 months · 108 in all · newest Nov 12, 2026 · oldest 2019
- Calls
- 16 calls with a replay · 16 with a transcript · latest May 8, 2025
- Decks
- 32 decks · latest Dec 11, 2024
Where Arcadia Biosciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:RKDA · Home listing · This page | NASDAQ | United States | USD |
| BOATS:RKDA | BOATS | United States | USD |
| gettex:17D | gettex | Germany | EUR |
| LS Exchange:A3D7B0 | LS Exchange | Germany | EUR |
| Frankfurt:17D | Frankfurt | Germany | EUR |
| Lang & Schwarz:A3D7B0 | Lang & Schwarz | Germany | EUR |
| Munich:17D | Munich | Germany | EUR |
Valuation
EV/sales −0.4× against a median of 0.9×: the lowest of 10 Food & drinks companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- −$1.80M USD
- P/E
- Loss
- EV/sales
- −0.4×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.4×
- Gross margin
- 41.1%
- Operating margin
- −69.0%
- Net margin
- −202.1%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 1.10
Food & drinks: the 10 companies nearest in size, of 642 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Arcadia Biosciences, Inc. · NASDAQ:RKDA | US$1.05M | −US$1.80M | n/a | −0.4× | n/a | 0.4× | −202.1% | 0.0× | 1.10 |
| Saudigold Group Bhd · MYX:SG | US$2.47M | US$21,382 | 6.4× | 0.0× | 0.0× | 0.1× | 1.8% | 0.0× | n/a |
| Rocky Mountain High Brands, Inc. · OTC:RMHB | US$2.27M | US$6.84M | 157× | 12.8× | n/a | n/a | 2.7% | n/a | 1.33 |
| Eneco Refresh Limited · ASX:ERG | US$2.16M | US$1.18M | 7.3× | 0.1× | 1.1× | 0.4× | 2.5% | 0.4× | n/a |
| Elixinol Wellness Ltd · ASX:EXL | US$1.80M | US$3.81M | n/a | 0.4× | n/a | 0.4× | −35.5% | 0.6× | n/a |
| Browar Czarnkow SA · NEWCONNECT:BRO | US$1.55M | US$1.55M | n/a | 0.9× | n/a | n/a | −25.1% | n/a | n/a |
| Caduceus Software Systems Corp. · OTC:CSOC | US$1.33M | US$10.73M | n/a | 1.8× | n/a | n/a | −59.3% | n/a | -0.18 |
| Sentient Brands Holdings Inc. · OTC:SNBH | US$1.31M | US$976,880 | n/a | n/a | n/a | n/a | n/a | n/a | 0.68 |
| Arctic Blue Beverages AB · OMXSTO:ARCTIC | US$1.02M | US$2.46M | n/a | 6.8× | n/a | n/a | −324.9% | n/a | n/a |
| American Rebel Holdings, Inc. · NASDAQ:AREB | US$1.02M | US$803,366 | n/a | 0.1× | n/a | n/a | −362.5% | n/a | 1.40 |
| Canyon Creek Food Company Ltd. · TSXV:CYF | US$490,188 | US$14.89M | n/a | 1.5× | n/a | n/a | −10.2% | n/a | -0.66 |
| Median of the others | US$1.44M | US$2.01M | 7.3× | 0.9× | 0.6× | 0.4× | −25.1% | 0.4× | 0.68 |
Forecasts
Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.
- Price target
- 12.00 USD · Analysts' mean
- EPS, year to Dec 2025
- -2.56 · 1 analyst
Team and board
| Director | Role |
|---|---|
| Kevin Comcowich | Chair of the Board |
| Amy Yoder | Director |
| Gregory D. Waller | Director |
| Lilian Shackelford Murray | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Arcadia Biosciences (NASDAQ:RKDA) Q1 2025 Earnings Call | Thu, May 08, 2025 · 2:00 PM ET | Replay |
| Arcadia Biosciences (NASDAQ:RKDA) Q4 2024 Earnings Call | Thu, Mar 20, 2025 · 4:30 PM ET | Replay |
| Arcadia Biosciences (NASDAQ:RKDA) Q3 2024 Earnings Call | Tue, Nov 12, 2024 · 4:30 PM ET | Replay |
| Arcadia Biosciences (NASDAQ:RKDA) Q1 2024 Earnings Call | Thu, May 09, 2024 · 4:30 PM ET | Replay |
| Arcadia Biosciences (NASDAQ:RKDA) Q4 2023 Earnings Call | Thu, Mar 28, 2024 · 4:30 PM ET | Replay |
| Arcadia Biosciences (NASDAQ:RKDA) Q3 2023 Earnings Call | Thu, Nov 09, 2023 · 4:30 PM ET | Replay |
| Arcadia Biosciences (NASDAQ:RKDA) Q2 2023 Earnings Call | Thu, Aug 10, 2023 · 4:30 PM ET | Replay |
| Arcadia Biosciences (NASDAQ:RKDA) Q1 2023 Earnings Call | Thu, May 11, 2023 · 4:30 PM ET | Replay |
| Arcadia Biosciences (NASDAQ:RKDA) Q4 2022 Earnings Call | Fri, Mar 31, 2023 · 4:30 PM ET | Replay |
| Arcadia Biosciences (NASDAQ:RKDA) Q3 2022 Earnings Call | Thu, Nov 10, 2022 · 4:30 PM ET | Replay |
All 16 calls
| Call | When | Status |
|---|---|---|
| Arcadia Biosciences (NASDAQ:RKDA) Q2 2022 Earnings Call | Thu, Aug 11, 2022 · 4:30 PM ET | Replay |
| Arcadia Biosciences (NASDAQ:RKDA) Q1 2022 Earnings Call | Thu, May 12, 2022 · 4:30 PM ET | Replay |
| Arcadia Biosciences (NASDAQ:RKDA) Q4 2021 Earnings Call | Wed, Mar 30, 2022 · 4:30 PM ET | Replay |
| Arcadia Biosciences (NASDAQ:RKDA) Q3 2021 Earnings Call | Mon, Nov 15, 2021 · 4:30 PM ET | Replay |
| Arcadia Biosciences (NASDAQ:RKDA) Q2 2021 Earnings Call | Mon, Aug 16, 2021 · 4:30 PM ET | Replay |
| Arcadia Biosciences (NASDAQ:RKDA) Q1 2021 Earnings Call | Mon, May 17, 2021 · 4:30 PM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 12, 2026 | −8.3% |
| Q2 2026 | Aug 13, 2026 | −10.7% |
| Q1 2026 | May 15, 2026 | −12.6% |
| Q4 2025 | Mar 19, 2026 · After close | +6.1% |
| Q3 2025 | Nov 7, 2025 · After close | −2.2% |
| Q2 2025 | Aug 14, 2025 · After close | +5.6% |
| Q1 2025 | May 7, 2025 · Before open | −2.0% |
| Q4 2024 | Mar 20, 2025 · After close | −4.5% |
| Q3 2024 | Nov 12, 2024 · After close | −1.2% |
| Q2 2024 | Aug 13, 2024 · After close | −11.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 9, 2024 · After close | −0.8% |
| Q4 2023 | Mar 28, 2024 · After close | −7.2% |
| Q3 2023 | Nov 9, 2023 · After close | −3.5% |
| Q2 2023 | Aug 10, 2023 · After close | −2.7% |
| Q1 2023 | May 15, 2023 · After close | −2.4% |
| Q4 2022 | Mar 30, 2023 · After close | −5.1% |
| Q3 2022 | Nov 10, 2022 · After close | −6.4% |
| Q2 2022 | Aug 11, 2022 · After close | +12.6% |
| Q1 2022 | May 12, 2022 · After close | +18.8% |
| Q4 2021 | Mar 30, 2022 · After close | −25.9% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (December 2024) | Merger or acquisition | 19 slides | Dec 11, 2024 |
| Investor Presentation (September 2023) | Investor deck | 34 slides | September 2023 |
| Investor Presentation (November 2021) | Investor deck | 17 slides | November 2021 |
| Q1 2021 Earnings Presentation | Earnings | 10 slides | May 17, 2021 |
| H.C. Wainwright Global Life Sciences Conference 2021 | Conference | 16 slides | March 2021 |
| Q3 2019 Earnings Presentation | Earnings | 7 slides | Nov 6, 2019 |
| Q2 2019 Earnings Presentation | Earnings | 7 slides | Aug 14, 2019 |
| Q1 2019 Earnings Presentation | Earnings | 9 slides | May 8, 2019 |
| Spring Investor Summit 2019 | Conference | 15 slides | Apr 1, 2019 |
| NobleConXV, 15th Annual Investor Conference (January 2019) | Conference | 19 slides | January 2019 |
All 32 decks
Financings
| Raise | Date |
|---|---|
| Private placement of common stock (or pre-funded warrants) with Series A-1 and A-2 preferred investment options Closed: US$4M raised · US$1.03 a share · Warrants at US$0.91 · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and general corporate purposes | Jun 13, 2026 |
| Warrant exercise of preferred investment options exercised for common stock Announced: about US$2.1M · US$2.575 a share · Warrants at US$2.325 for 30 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and general corporate purposes | Jan 12, 2026 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$8.00 a share on May 14, 2015.
- Price
- US$8.00 a share
- Shares offered
- 8,200,000 shares of common stock
- Offering size
- US$65.6 million
- Listing
- RKDA on the Nasdaq Global Market
- Underwriters
- Credit Suisse, J.P. Morgan, Piper Jaffray · In the order on the cover
- Shares delivered
- On or about May 20, 2015
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Nov 12, 2014 |
| Filed publicly | Feb 17, 2015 |
| Amended 4 times | Newest May 14, 2015 |
| Shares registered with an exchange | May 8, 2015 |
| Declared effective by the SEC | May 14, 2015 |
| Final prospectus, with the price | May 15, 2015 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | May 15, 2015 |
| CERTNAS · Nasdaq's certificate of listing | May 15, 2015 |
| EFFECT · Notice that a registration is effective | May 14, 2015 |
| 8-A12B/A · Registration of shares for listing on an exchange, amended | May 14, 2015 |
| CORRESP · Letter to the SEC | May 14, 2015 |
| S-1/A · Registration statement, amended | May 14, 2015 |
| CORRESP · Letter to the SEC | May 13, 2015 |
| CERTNAS · Nasdaq's certificate of listing | May 11, 2015 |
| CORRESP · Letter to the SEC | May 11, 2015 |
| S-1/A · Registration statement, amended | May 11, 2015 |
All 27 filings
| Filing | Filed |
|---|---|
| CORRESP · Letter to the SEC | May 8, 2015 |
| UPLOAD · Letter from the SEC | May 8, 2015 |
| 8-A12B · Registration of shares for listing on an exchange | May 8, 2015 |
| CORRESP · Letter to the SEC | Apr 30, 2015 |
| S-1/A · Registration statement, amended | Apr 30, 2015 |
| UPLOAD · Letter from the SEC | Apr 10, 2015 |
| S-1/A · Registration statement, amended | Apr 6, 2015 |
| CORRESP · Letter to the SEC | Apr 3, 2015 |
| UPLOAD · Letter from the SEC | Mar 2, 2015 |
| CORRESP · Letter to the SEC | Feb 23, 2015 |
| S-1 · Registration statement | Feb 17, 2015 |
| UPLOAD · Letter from the SEC | Dec 30, 2014 |
| DRSLTR · Letter to the SEC with a draft | Dec 22, 2014 |
| DRS/A · Draft registration statement, amended | Dec 22, 2014 |
| UPLOAD · Letter from the SEC | Dec 8, 2014 |
| DRSLTR · Letter to the SEC with a draft | Nov 12, 2014 |
| DRS · Draft registration statement | Nov 12, 2014 |
Open IPO · From the cover of the final prospectus (424B4) filed May 15, 2015
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.86M | 5.04M | 4.45M | 7.42M | 6.78M | 8.03M | 1.17M | 1.46M | 4.03M | 3.19M |
| Cost of revenue | 3.10M | 2.96M | 2.17M | 6.10M | 8.71M | 5.20M | 885.0K | 661.0K | 283.0K | 895.0K |
| Gross profit | 1.76M | 2.08M | 2.28M | 1.32M | -1.93M | 2.83M | 284.0K | 803.0K | 3.74M | 2.29M |
| Research and development | 9.00K | 53.0K | 64.0K | 1.51M | 3.89M | 7.96M | 7.10M | 6.07M | 7.41M | 8.66M |
| Selling, general and administrative | 7.00M | 9.64M | 8.23M | 15.0M | 22.9M | 16.5M | 13.6M | 11.6M | 10.7M | 12.3M |
| Operating income | -2.50M | -3.65M | -6.10M | -14.0M | -35.5M | -12.8M | -19.4M | -16.9M | -14.3M | -18.6M |
| Depreciation and amortization | 32.0K | 58.0K | 111.0K | 439.0K | 929.0K | 632.0K | 194.0K | 154.0K | 279.0K | 304.0K |
| EBITDA | -2.47M | -3.59M | -5.99M | -13.6M | -34.6M | -12.1M | -19.2M | -16.7M | -14.0M | -18.3M |
| Interest expense | 289.0K | 20.0K | 47.0K | 5.00K | 2.56M | 747.0K | 1.32M | |||
| Income before tax | -2.33M | -4.31M | -5.32M | -10.8M | -16.1M | -6.15M | -28.9M | -13.5M | -15.7M | -19.6M |
| Income tax | 8.00K | 8.00K | 8.00K | 14.0K | 2.00K | -124.0K | 2.00K | 10.0K | 26.0K | 25.0K |
| Net income | -2.34M | -7.04M | -14.0M | -15.4M | -14.7M | -4.66M | -28.8M | -13.5M | -15.7M | -19.6M |
| Earnings per share, basic | -1.71 | -5.17 | -11.29 | -25.65 | -27.56 | -0.47 | -4.53 | -3.58 | -7.28 | -8.85 |
| Earnings per share, diluted | -1.71 | -5.17 | -11.29 | -25.65 | -27.56 | -0.47 | -4.53 | -3.58 | -7.28 | -8.85 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 259.0K | 4.24M | 6.52M | 20.6M | 28.7M | 14.0M | 8.42M | 12.0M | 9.13M | 2.01M |
| Short-term investments | 4.30M | 0 | 5.12M | 0 | 0 | 11.6M | 16.9M | 9.82M | 3.90M | 48.5M |
| Receivables | 425.0K | 1.18M | 514.0K | 1.22M | 1.37M | 1.41M | 602.0K | 165.0K | 1.23M | 349.0K |
| Inventory | 1.21M | 904.0K | 837.0K | 2.32M | 4.43M | 3.81M | 1.79M | 181.0K | 229.0K | 252.0K |
| Current assets | 6.36M | 9.24M | 15.0M | 25.4M | 35.4M | 31.7M | 28.4M | 22.9M | 15.0M | 52.2M |
| Property, plant and equipment | 8.00K | 41.0K | 70.0K | 680.0K | 2.29M | 3.54M | 1.80M | 395.0K | 299.0K | 508.0K |
| Goodwill | 0 | 408.0K | 0 | 0 | 0 | |||||
| Total assets | 6.55M | 13.5M | 19.7M | 28.9M | 43.9M | 47.3M | 32.6M | 24.0M | 16.6M | 56.6M |
| Accounts payable | 1.45M | 703.0K | 801.0K | 905.0K | 1.41M | 726.0K | 492.0K | 285.0K | 366.0K | 222.0K |
| Current liabilities | 2.06M | 2.56M | 3.59M | 4.21M | 5.04M | 6.31M | 5.71M | 3.05M | 3.52M | 3.13M |
| Long-term debt | 0 | 2.10M | 107.0K | 0 | 25.1M | |||||
| Total debt | 155.0K | 1.01M | 2.02M | 0 | 2.10M | 107.0K | 0 | 0 | 25.1M | |
| Total liabilities | 2.41M | 7.29M | 7.00M | 8.02M | 12.7M | 18.8M | 24.2M | 11.2M | 8.56M | 34.4M |
| Shareholders' equity | 4.14M | 6.22M | 12.8M | 21.0M | 31.1M | 27.7M | 7.71M | 12.8M | 8.01M | 22.2M |
| Shares outstanding | 1.37M | 1.36M | 1.29M | 616.1K | 554.6K | 13.5M | 8.65M | 4.77M | 2.13M | 2.22M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -4.70M | -9.63M | -15.3M | -14.0M | -25.9M | -30.2M | -17.2M | -13.6M | -14.0M | -17.1M |
| Capital spending | 0 | -16.0K | -5.00K | -72.0K | -1.01M | -2.33M | -1.48M | -250.0K | -79.0K | -231.0K |
| Free cash flow | -4.70M | -9.64M | -15.3M | -14.0M | -26.9M | -32.6M | -18.7M | -13.9M | -14.0M | -17.3M |
| Cash from investing | 750.0K | 7.34M | -4.34M | 1.42M | 16.6M | 17.3M | -8.37M | -5.97M | 47.2M | -5.30M |
| Cash from financing | 6.00K | 9.00K | 5.51M | 4.52M | 21.9M | 20.6M | 22.0M | 22.5M | -26.1M | 396.0K |
| Dividends paid | 0 | 0 | ||||||||
| Share buybacks | 25.1M | 9.42M | 5.29M | 10.0M | 24.0K | 442.0K | ||||
| Change in cash | -3.98M | -2.28M | -14.1M | -8.04M | 12.6M | 7.63M | -3.58M | 2.87M | 7.11M | -22.0M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 16, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 12, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 12, 2026 | Results | SEC |
| S-8 · Registration statement for employee plans | Sep 30, 2026 | Offer document | SEC |
| SCHEDULE 13G · Big-stake notice | Sep 30, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Sep 15, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Sep 14, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 14, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 14, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 14, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Sep 4, 2026 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 13, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 13, 2026 | Results | SEC |
| ARS · Annual report to shareholders | Aug 10, 2026 | Annual report | SEC |
| DEF 14A · Proxy statement | Aug 10, 2026 | Meeting notice | SEC |
| 8-K · Current report | Aug 7, 2026 | Current report | SEC |
| PRE 14A · Preliminary proxy statement | Jul 31, 2026 | Meeting notice | SEC |
| EFFECT · Notice that a registration is effective | Jul 9, 2026 | Other filings | SEC |
| 424B3 · Prospectus | Jul 8, 2026 | Offer document | SEC |
| 8-K · Current report | Jul 2, 2026 | Management or board change | SEC |
| D | Jun 26, 2026 | Other filings | SEC |
| S-3 · Registration statement | Jun 26, 2026 | Offer document | SEC |
| 8-K · Current report | Jun 15, 2026 | Material contract | SEC |
| SCHEDULE 13G · Big-stake notice | May 15, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 14, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 14, 2026 | Results | SEC |
| 10-K/A · Annual report, amended | Apr 30, 2026 | Annual report | SEC |
| 8-K · Current report | Apr 3, 2026 | Current report | SEC |
| 10-K · Annual report | Mar 26, 2026 | Annual report | SEC |
| 8-K · Current report | Mar 26, 2026 | Results | SEC |
| EFFECT · Notice that a registration is effective | Feb 11, 2026 | Other filings | SEC |
| 424B3 · Prospectus | Feb 10, 2026 | Offer document | SEC |
| 8-K · Current report | Feb 6, 2026 | Management or board change | SEC |
| CORRESP · Letter to the SEC | Feb 5, 2026 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Feb 5, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 27, 2026 | Other filings | SEC |
| S-3 · Registration statement | Jan 27, 2026 | Offer document | SEC |
| D | Jan 26, 2026 | Other filings | SEC |
| RW · Request to withdraw a registration | Jan 16, 2026 | Other filings | SEC |
| 8-K · Current report | Jan 13, 2026 | Material contract | SEC |
| 425 | Dec 29, 2025 | Other filings | SEC |
| 8-K · Current report | Dec 29, 2025 | Current report | SEC |
| 8-K · Current report | Dec 23, 2025 | Meeting outcome | SEC |
| ARS · Annual report to shareholders | Nov 19, 2025 | Annual report | SEC |
| DEF 14A · Proxy statement | Nov 19, 2025 | Meeting notice | SEC |
| 10-Q · Quarterly report | Nov 7, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 7, 2025 | Results | SEC |
| 8-K · Current report | Oct 24, 2025 | Current report | SEC |
| 8-K · Current report | Aug 29, 2025 | Management or board change | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 19, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| 425 | Aug 14, 2025 | Other filings | SEC |
| 8-K · Current report | Aug 14, 2025 | Results | SEC |
| S-4/A · Registration statement, amended | Jul 30, 2025 | Offer document | SEC |
| 8-K · Current report | May 16, 2025 | Current report | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | May 8, 2025 | Quarterly report | SEC |
| 425 | May 8, 2025 | Other filings | SEC |
| 8-K · Current report | May 8, 2025 | Results | SEC |
| 425 | May 2, 2025 | Other filings | SEC |
| 8-K · Current report | May 2, 2025 | Material contract | SEC |
| 10-K/A · Annual report, amended | Apr 30, 2025 | Annual report | SEC |
| 8-K · Current report | Apr 3, 2025 | Material contract | SEC |
| 10-K · Annual report | Mar 25, 2025 | Annual report | SEC |
| 8-K · Current report | Mar 20, 2025 | Results | SEC |
| S-4 · Registration statement | Feb 14, 2025 | Offer document | SEC |
| 4 · Change in ownership | Feb 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jan 3, 2025 | Big-stake notice | SEC |
| 425 | Dec 11, 2024 | Other filings | SEC |
| 8-K · Current report | Dec 11, 2024 | Current report | SEC |
| 425 | Dec 5, 2024 | Other filings | SEC |
| 8-K · Current report | Dec 5, 2024 | Material contract | SEC |
| S-8 · Registration statement for employee plans | Nov 22, 2024 | Offer document | SEC |
| 10-Q · Quarterly report | Nov 12, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 12, 2024 | Results | SEC |
| 8-K/A · Current report, amended | Aug 23, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Aug 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 13, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 13, 2024 | Results | SEC |
| 8-K · Current report | Aug 7, 2024 | Management or board change | SEC |
| 3 · Initial statement of ownership | Jul 18, 2024 | Insider trade | SEC |
| 8-K · Current report | Jul 8, 2024 | Management or board change | SEC |
| 8-K · Current report | Jul 1, 2024 | Meeting outcome | SEC |
| 8-K · Current report | May 20, 2024 | Acquisition or disposal | SEC |
| 8-K · Current report | May 17, 2024 | Acquisition or disposal | SEC |
| DEFA14A · Additional proxy material | May 16, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | May 16, 2024 | Meeting notice | SEC |
| 10-Q · Quarterly report | May 13, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 9, 2024 | Results | SEC |
| 10-K/A · Annual report, amended | Apr 29, 2024 | Annual report | SEC |
| 10-K · Annual report | Mar 28, 2024 | Annual report | SEC |
| 8-K · Current report | Mar 28, 2024 | Results | SEC |
| 8-K · Current report | Feb 14, 2024 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 5, 2024 | Insider trade | SEC |
| SC 13G · Big-stake notice | Jan 3, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 9, 2023 | Quarterly report | SEC |
| 8-K · Current report | Nov 9, 2023 | Results | SEC |
| 10-Q · Quarterly report | Aug 10, 2023 | Quarterly report | SEC |
| 8-K · Current report | Aug 10, 2023 | Results | SEC |
| 4 · Change in ownership | Aug 7, 2023 | Insider trade | SEC |
| 8-K · Current report | Jul 20, 2023 | Results | SEC |
| 4 · Change in ownership | Jun 16, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2023 | Insider trade | SEC |
| 8-K · Current report | Jun 12, 2023 | Meeting outcome | SEC |
| 4 · Change in ownership | May 30, 2023 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | May 25, 2023 | Offer document | SEC |
| 10-Q · Quarterly report | May 15, 2023 | Quarterly report | SEC |
| 8-K · Current report | May 11, 2023 | Results | SEC |
| 4 · Change in ownership | Apr 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Apr 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Apr 28, 2023 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Apr 25, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 25, 2023 | Meeting notice | SEC |
| EFFECT · Notice that a registration is effective | Apr 18, 2023 | Other filings | SEC |
| 424B3 · Prospectus | Apr 17, 2023 | Offer document | SEC |
| CORRESP · Letter to the SEC | Apr 13, 2023 | Other filings | SEC |
| 10-K/A · Annual report, amended | Apr 13, 2023 | Annual report | SEC |
| UPLOAD · Letter from the SEC | Apr 10, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Apr 3, 2023 | Other filings | SEC |
| S-3 · Registration statement | Apr 3, 2023 | Offer document | SEC |
| 10-K · Annual report | Mar 30, 2023 | Annual report | SEC |
| 8-K · Current report | Mar 30, 2023 | Results | SEC |
| 424B3 · Prospectus | Mar 3, 2023 | Offer document | SEC |
| 424B3 · Prospectus | Mar 3, 2023 | Offer document | SEC |
| 424B3 · Prospectus | Mar 3, 2023 | Offer document | SEC |
| 424B3 · Prospectus | Mar 3, 2023 | Offer document | SEC |
| 424B3 · Prospectus | Mar 3, 2023 | Offer document | SEC |
| 8-K · Current report | Mar 3, 2023 | Material contract | SEC |
| 8-K · Current report | Feb 28, 2023 | Current report | SEC |
| 8-K · Current report | Feb 22, 2023 | Meeting outcome | SEC |
| SC 13G · Big-stake notice | Feb 14, 2023 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 2, 2023 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Jan 20, 2023 | Big-stake notice | SEC |
| DEF 14A · Proxy statement | Jan 6, 2023 | Meeting notice | SEC |
| 4 · Change in ownership | Jan 5, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 5, 2023 | Insider trade | SEC |
| 8-K/A · Current report, amended | Jan 5, 2023 | Management or board change | SEC |
| PRE 14A · Preliminary proxy statement | Dec 23, 2022 | Meeting notice | SEC |
| 8-K · Current report | Dec 8, 2022 | Current report | SEC |
| 8-A12G · Registration of a class of shares | Dec 8, 2022 | Other filings | SEC |
| 8-K · Current report | Nov 30, 2022 | Management or board change | SEC |
| 10-Q · Quarterly report | Nov 10, 2022 | Quarterly report | SEC |
| 8-K · Current report | Nov 10, 2022 | Results | SEC |
| 424B3 · Prospectus | Oct 7, 2022 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Oct 6, 2022 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 4, 2022 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Oct 3, 2022 | Other filings | SEC |
| S-1 · Registration statement | Sep 27, 2022 | Offer document | SEC |
| 8-K · Current report | Sep 27, 2022 | Current report | SEC |
| 4 · Change in ownership | Aug 18, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2022 | Insider trade | SEC |
| 8-K · Current report | Aug 16, 2022 | Material contract | SEC |
| 424B5 · Prospectus | Aug 16, 2022 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 11, 2022 | Quarterly report | SEC |
| 8-K · Current report | Aug 11, 2022 | Results | SEC |
| 4 · Change in ownership | Aug 3, 2022 | Insider trade | SEC |
| 8-K · Current report | Jun 7, 2022 | Management or board change | SEC |
| 4 · Change in ownership | Jun 3, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2022 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | May 31, 2022 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | May 13, 2022 | Other filings | SEC |
| 10-Q · Quarterly report | May 12, 2022 | Quarterly report | SEC |
| 8-K · Current report | May 12, 2022 | Results | SEC |
| CORRESP · Letter to the SEC | May 10, 2022 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Apr 27, 2022 | Other filings | SEC |
| S-3 · Registration statement | Apr 21, 2022 | Offer document | SEC |
| DEFA14A · Additional proxy material | Apr 19, 2022 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 19, 2022 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 13, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Apr 13, 2022 | Insider trade | SEC |
| 10-K · Annual report | Mar 31, 2022 | Annual report | SEC |
| 8-K · Current report | Mar 30, 2022 | Results | SEC |
| 424B3 · Prospectus | Feb 11, 2022 | Offer document | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 11, 2022 | Big-stake notice | SEC |
| EFFECT · Notice that a registration is effective | Feb 10, 2022 | Other filings | SEC |
| 8-K · Current report | Feb 7, 2022 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 4, 2022 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 4, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 4, 2022 | Insider trade | SEC |
This page holds 200 of 599 filings. Open Filings
Cap table
Built by 6ix from Arcadia Biosciences, Inc.’s releases · as of Nov 5, 2026
- Common shares
- 6,065,211
- Fully diluted
- 6,065,211
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 6,065,211 | Nov 5, 2026 |
Warrants and options
| Lot |
|---|
| Warrants · US$0.91 · expiry not stated |
Share count over time
| Count | Shares |
|---|---|
| Nov 5, 2026 | 6,065,211 |
| Jun 29, 2026 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Gregory D. Waller Other companies: Nuwellis, Inc. (Member of the Compensation Committee · Since at least Feb 14, 2012); Senorx Inc (Director · Mar 27, 2007 – Feb 26, 2010 · Past); Clarient Inc (Director · Dec 1, 2006 – Dec 22, 2010 · Past); Endologix Inc (Director · May 23, 2006 – Aug 12, 2020 · Past) | Director · Since at least Jun 7, 2017 |
| Albert D Bolles Other companies: Lifecore Biomedical, Inc. (Chief Executive Officer · May 8, 2014 – May 23, 2022 · Past); ConAgra Brands, Inc. (EVP & Chief Tech & Op Officer · Mar 14, 2014 – Jul 17, 2015 · Past) | Director · May 12, 2018 – Aug 19, 2024 · Past |
| Mark Wong Other companies: S&W Seed Company (Director · Jun 30, 2015 – Dec 17, 2024 · Past); Green Brick Partners, Inc. (Director · Jan 16, 2008 – Mar 15, 2012 · Past) | Director · May 14, 2015 – Sep 9, 2015 · Past |
| Rajiv Shah Other companies: Omeros Corporation (Director · Since at least Jun 14, 2015); Khosla Ventures Acquisition Co (Director · Mar 3, 2021 – Mar 3, 2021 · Past) | Director · May 14, 2015 – Aug 18, 2016 · Past |
| Amy Yoder Other companies: Compass Minerals Intl Inc (Director · May 21, 2012 – Feb 14, 2023 · Past) | Director · Since at least Aug 7, 2017 |
| Darby E Shupp Other companies: Apollo Education Group Inc (Director · Mar 24, 2011 – Feb 1, 2017 · Past) | Director · May 14, 2015 – Aug 18, 2016 · Past |
| Deborah D Carosella Other companies: Lifecore Biomedical, Inc. (Director · Mar 14, 2017 – Jun 4, 2022 · Past) | Director · Feb 22, 2021 – Aug 19, 2024 · Past |
| Eric J Rey Other companies: 4Front Ventures Corp. (Director · Jan 1, 2021 – Jan 1, 2021 · Past) | Director · May 14, 2015 – Jun 3, 2019 · Past |
| George Frederick John Gosbee Other companies: BioAmber Inc (BIOA) (Director · Feb 22, 2016 – Nov 9, 2016 · Past) | Director · May 14, 2015 – Jun 7, 2017 · Past |
| James Richard Reis Other companies: Apollo Education Group Inc (Director · Jan 12, 2007 – Jul 6, 2010 · Past) | Director · May 14, 2015 – Jul 9, 2016 · Past |
All 28 people
| Person | Seat |
|---|---|
| Matthew T Plavan Other companies: Origin Materials, Inc. (CFO and COO · Since at least Oct 30, 2023) | Chief Executive Officer · Sep 12, 2016 – Jan 21, 2021 · Past |
| Pamela Haley Other companies: Origin Materials, Inc. (Interim CFO · Sep 1, 2023 – Sep 1, 2023 · Past) | Chief Financial Officer · Sep 1, 2019 – Aug 16, 2022 · Past |
| Sarah Reiter Other companies: Cibus, Inc. (Chief Business Officer · May 1, 2021 – Jun 8, 2021 · Past) | Chief Commercial Officer · Mar 19, 2018 – Feb 3, 2020 · Past |
| Chris Cuvelier | Chief Growth Officer · May 17, 2021 – May 17, 2021 · Past |
| Don Emlay | VP Regulatory and Compliance · May 14, 2015 – Sep 10, 2015 · Past |
| Kevin Comcowich | Chair of the Board · Since at least Jun 1, 2022 |
| Laura Pitlik | Chief Marketing Officer · Jul 12, 2021 – Apr 4, 2023 · Past |
| Lilian Shackelford Murray | Director · Since at least Jun 6, 2018 |
| Mark Kawakami | Chief Financial Officer · Jul 5, 2024 – May 9, 2025 · Past |
| Matthew A Ankrum | Director · Jul 9, 2016 – Jul 9, 2016 · Past |
| Rajendra D Ketkar | Chief Executive Officer, Director · May 23, 2016 – Jun 3, 2019 · Past |
| Randall Shultz | Chief Technology Officer · Apr 1, 2020 – Jan 21, 2021 · Past |
| Roger Salameh | Chief Operating Officer · May 14, 2015 – Aug 18, 2016 · Past |
| Stanley Jacot Jr | Chief Executive Officer · Feb 2, 2022 – May 30, 2023 · Past |
| Thomas J Schaefer | Chief Executive Officer · Jan 3, 2023 – May 9, 2025 · Past |
| Vic C Knauf | Chief Scientific Officer, Director · May 14, 2015 – Aug 18, 2016 · Past |
| Wendy S Neal | VP, Chief Legal Officer · May 12, 2015 – Aug 18, 2016 · Past |
| Zhongjin Lu | VP Product Development · May 14, 2015 – Mar 23, 2018 · Past |
Log in to ask 6ix AI your own questions about Arcadia Biosciences, Inc.